Arun Azad, Neeraj Agarwal, Andrew J. Armstrong, Eva Hellmis, Friederike Schlürmann, Mikio Sugimoto, Yüksel Ürün, Nianzeng Xing, Mehreteab Aregay, Julianne Lima, Didier Meulendijks, Kim N. Chi. "Phase III, double-blind, placebo-controlled, 2-cohort, randomized study of saruparib (AZD5305) in combination with androgen receptor pathway inhibitors in patients with metastatic hormone-sensitive prostate cancer with and without homologous recombination repair mutation (EvoPAR-Prostate01).." Journal of Clinical Oncology (2025). https://doi.org/10.1200/jco.2025.43.5_suppl.tps279